NCT00000704View on ClinicalTrials.gov

A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.

PHASE1CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 1990

Conditions

HIV Infections

Interventions

DRUG

Zalcitabine

Trial Locations (1)

331361013

Univ. of Miami AIDS CRS, Miami

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH